FibroBiologics (FBLG) Price to Book (2024 - 2026)

FibroBiologics (FBLG) has reported Price to Book for 3 consecutive years, with 1.36 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book fell 95.5% year-over-year to 1.36; the trailing twelve-month figure through Jun 2026 stood at 1.36 (down 95.5% YoY), and the FY2025 full-year result was 2.43, down 91.19% from the prior year.
• Price to Book declined to 1.36 in Q2 2026 per FBLG's latest filing, from 1.92 in the prior quarter.
• Across five years, Price to Book topped out at 224.76 in Q3 2025 and bottomed at 73.5 in Q2 2024.
• Historically, Price to Book has averaged 27.22 across 3 years, with a median of 9.1 in 2024.
• The sharpest annual moves came in 2025 and 2026: Price to Book jumped 474.4% in 2025, then sank 95.5% in 2026.
• Over 3 years, Price to Book stood at 27.59 in 2024, then plunged by 91.19% to 2.43 in 2025, then plunged by 43.88% to 1.36 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 1.36, 1.92, and 2.43 for Q2 2026, Q1 2026, and Q4 2025 respectively.